Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
28
DGX Quote, Financials, Valuation and Earnings
Last price:
$153.13
Seasonality move
:
0%
Day range:
$151.68 - $154.10
52-week range:
$123.04 - $165.32
Dividend yield:
1.93%
P/E ratio:
20.58x
P/S ratio:
1.80x
P/B ratio:
2.51x
Volume:
1.2M
Avg. volume:
917.6K
1-year change:
13.6%
Market cap:
$17.1B
Revenue:
$9.3B
EPS (TTM):
$7.44
Earnings Data
Next earnings date for DGX
Jan 31
2025
Most recent earnings per share
$1.99
Missed by $0.27
(Oct 22/2024)
Consensus Estimate
$2.26
(Oct 22/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
DGX Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 01/31/2025 | Q4 | $2.6B | -- | -- | $2.19 | -- |
| 10/22/2024 | Q3 | $2.4B | $2.5B | $1.99 | $2.26 | -$0.27 |
| 07/23/2024 | Q2 | $2.4B | $2.4B | $2.03 | $2.33 | -$0.30 |
| 04/23/2024 | Q1 | $2.3B | $2.4B | $1.72 | $1.86 | -$0.14 |
| 02/01/2024 | Q4 | $2.3B | $2.3B | $1.70 | $2.11 | -$0.41 |
| 10/24/2023 | Q3 | -- | -- | $1.96 | $2.19 | -$0.23 |
| 07/26/2023 | Q2 | -- | -- | $2.05 | $2.26 | -$0.21 |
| 04/27/2023 | Q1 | -- | -- | $1.78 | $1.97 | -$0.19 |
| 02/02/2023 | Q4 | -- | -- | $0.87 | $1.90 | -$1.03 |
| 10/20/2022 | Q3 | -- | -- | $2.17 | $2.19 | -$0.02 |
| 07/21/2022 | Q2 | -- | -- | $1.96 | $2.27 | -$0.31 |
| 04/21/2022 | Q1 | -- | -- | $2.92 | $3.00 | -$0.08 |
| 02/03/2022 | Q4 | -- | -- | $3.12 | $3.21 | -$0.09 |
| 10/21/2021 | Q3 | -- | -- | $4.02 | $3.06 | $0.96 |
| 07/22/2021 | Q2 | -- | -- | $4.96 | $2.86 | $2.10 |
| 04/22/2021 | Q1 | -- | -- | $3.46 | $3.73 | -$0.27 |
| 02/04/2021 | Q4 | -- | -- | $4.21 | $4.24 | -$0.03 |
| 10/22/2020 | Q3 | -- | -- | $4.14 | $3.73 | $0.41 |
| 07/23/2020 | Q2 | -- | -- | $1.36 | $1.25 | $0.11 |
| 04/22/2020 | Q1 | -- | -- | $0.73 | $0.88 | -$0.15 |
| 01/30/2020 | Q4 | -- | -- | $1.86 | $1.60 | $0.26 |
| 10/22/2019 | Q3 | -- | -- | $1.56 | $1.71 | -$0.15 |
| 07/23/2019 | Q2 | -- | -- | $1.73 | $1.68 | $0.05 |
| 04/23/2019 | Q1 | -- | -- | $1.40 | $1.38 | $0.02 |
| 02/14/2019 | Q4 | -- | -- | $1.36 | $1.37 | -$0.01 |
| 10/23/2018 | Q3 | -- | -- | $1.68 | $1.68 | $0.00 |
| 07/24/2018 | Q2 | -- | -- | $1.75 | $1.76 | -$0.01 |
| 04/19/2018 | Q1 | -- | -- | $1.52 | $1.50 | $0.02 |
| 02/01/2018 | Q4 | -- | -- | $1.40 | $1.37 | $0.03 |
| 10/19/2017 | Q3 | -- | -- | $1.39 | $1.36 | $0.03 |
| 07/25/2017 | Q2 | -- | -- | $1.55 | $1.42 | $0.13 |
| 04/20/2017 | Q1 | -- | -- | -- | $1.18 | -- |
| 01/26/2017 | Q4 | -- | -- | $1.31 | $1.27 | $0.04 |
| 10/20/2016 | Q3 | -- | -- | $1.37 | $1.35 | $0.02 |
| 07/21/2016 | Q2 | -- | -- | $1.34 | $1.31 | $0.03 |
| 04/21/2016 | Q1 | -- | -- | $1.12 | $1.12 | -- |
| 01/28/2016 | Q4 | -- | -- | $1.19 | $1.19 | -- |
| 10/22/2015 | Q3 | -- | -- | $1.28 | $1.27 | $0.01 |
| 07/23/2015 | Q2 | -- | -- | $1.25 | $1.24 | $0.01 |
| 04/23/2015 | Q1 | -- | -- | $1.05 | $1.02 | $0.03 |
| 01/29/2015 | Q4 | -- | -- | $1.08 | $1.05 | $0.03 |
Quest Diagnostics Earnings Questions
-
How Much did Quest Diagnostics Generate in Revenue Last Quarter?
Quest Diagnostics reported $2.5B worth of top line sales in its most recent quarter.
-
Did Quest Diagnostics Beat Earnings Last Quarter?
Quest Diagnostics announced earnings per share of $1.99 which represents a miss of analyst forecast a $2.26 per share.
-
Is Quest Diagnostics Profitable?
Quest Diagnostics reported $811M that represents $7.18 per share over the last quarter.
-
What is the Analyst Consensus for Quest Diagnostics EPS Next Year?
Quest Diagnostics's earnings are forecast to grow from $7.49 per share to $8.71 per share next year representing an increase of 18.82%.
-
When is Quest Diagnostics's Earnings Date?
Quest Diagnostics's next earnings date is January 31, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
